You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 28, 2024

Details for New Drug Application (NDA): 017398

✉ Email this page to a colleague

« Back to Dashboard

NDA 017398 describes REGONOL, which is a drug marketed by Sandoz and is included in one NDA. It is available from one supplier. Additional details are available on the REGONOL profile page.

The generic ingredient in REGONOL is pyridostigmine bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 017398
Ingredient:pyridostigmine bromide
Formulation / Manufacturing:see details
Pharmacology for NDA: 017398
Mechanism of ActionCholinesterase Inhibitors
Medical Subject Heading (MeSH) Categories for 017398
Suppliers and Packaging for NDA: 017398
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
REGONOL pyridostigmine bromide INJECTABLE;INJECTION 017398 NDA Sandoz Inc 0781-3040 0781-3040-95 10 AMPULE in 1 CARTON (0781-3040-95) / 2 mL in 1 AMPULE (0781-3040-72)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.